Wilson Sonsini is pleased to be a 2025 sponsor of the Pharmaceutical and Biomedical Sciences Society International (PBSS).

As the field of drug development continues to evolve, the formulation of small synthetic molecules remains a critical component in the journey from discovery to early clinical trials. This workshop aims to deepen participants' understanding of the key strategies and challenges in preclinical and early clinical formulation development. Experts will share their insights on the physicochemical properties of APIs, approaches to formulation screening and characterization, and the transition from preclinical to clinical stages. Partner Deborah Smith will present, IP Strategies for Protecting Formulation Technologies and Compositions, at the event. Attendees will also explore enabling formulation strategies to overcome exposure challenges with difficult molecules, ensuring a comprehensive grasp of the formulation process.